allogeneic hematopoietic stem cell transplantation + Pharmacological Study + CLOFARABINE + Melphalan + Sirolimus + Tacrolimus for myelodysplastic syndromes
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.
Put together by software, not yet checked by a person
Why this status
25 Jun 2013: Trial registered, NCT01885689
10 Feb 2014: Trial started, NCT01885689
The trials
NCT01885689: Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia
State
Under way
Phase
Phase 2
People
72 taking part
Started
10 Feb 2014
Primary completion
27 Dec 2019
Arms
Treatment (clofarabine, melphalan, transplant)
Results
Posted on the registry
25 Jun 2013: Trial registered
10 Feb 2014: Trial started
4 Apr 2023: Trial results posted
How the status changed
19 Nov 2026: First set: Phase 2 trial
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.